267 related articles for article (PubMed ID: 24891386)
1. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development.
Wang L; Wansleeben C; Zhao S; Miao P; Paschen W; Yang W
EMBO Rep; 2014 Aug; 15(8):878-85. PubMed ID: 24891386
[TBL] [Abstract][Full Text] [Related]
2. The requirement of SUMO2/3 for SENP2 mediated extraembryonic and embryonic development.
Yu HI; Hsu T; Maruyama EO; Paschen W; Yang W; Hsu W
Dev Dyn; 2020 Feb; 249(2):237-244. PubMed ID: 31625212
[TBL] [Abstract][Full Text] [Related]
3. Loss of SUMO1 in mice affects RanGAP1 localization and formation of PML nuclear bodies, but is not lethal as it can be compensated by SUMO2 or SUMO3.
Evdokimov E; Sharma P; Lockett SJ; Lualdi M; Kuehn MR
J Cell Sci; 2008 Dec; 121(Pt 24):4106-13. PubMed ID: 19033381
[TBL] [Abstract][Full Text] [Related]
4. Senp1 is essential for desumoylating Sumo1-modified proteins but dispensable for Sumo2 and Sumo3 deconjugation in the mouse embryo.
Sharma P; Yamada S; Lualdi M; Dasso M; Kuehn MR
Cell Rep; 2013 May; 3(5):1640-50. PubMed ID: 23684609
[TBL] [Abstract][Full Text] [Related]
5. SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner.
Sang J; Yang K; Sun Y; Han Y; Cang H; Chen Y; Shi G; Wang K; Zhou J; Wang X; Yi J
Biochem J; 2011 Apr; 435(2):489-98. PubMed ID: 21291420
[TBL] [Abstract][Full Text] [Related]
6. Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.
Yang W; Sheng H; Thompson JW; Zhao S; Wang L; Miao P; Liu X; Moseley MA; Paschen W
Stroke; 2014 Apr; 45(4):1115-22. PubMed ID: 24569813
[TBL] [Abstract][Full Text] [Related]
7. SUMO paralogue-specific functions revealed through systematic analysis of human knockout cell lines and gene expression data.
Bouchard D; Wang W; Yang WC; He S; Garcia A; Matunis MJ
Mol Biol Cell; 2021 Sep; 32(19):1849-1866. PubMed ID: 34232706
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation.
Liu YY; Kogai T; Schultz JJ; Mody K; Brent GA
J Biol Chem; 2012 Oct; 287(43):36499-508. PubMed ID: 22930759
[TBL] [Abstract][Full Text] [Related]
9. SUMO2/3 conjugation is an endogenous neuroprotective mechanism.
Datwyler AL; Lättig-Tünnemann G; Yang W; Paschen W; Lee SL; Dirnagl U; Endres M; Harms C
J Cereb Blood Flow Metab; 2011 Nov; 31(11):2152-9. PubMed ID: 21863037
[TBL] [Abstract][Full Text] [Related]
10. SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response.
Crowl JT; Stetson DB
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):6798-6803. PubMed ID: 29891701
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal distribution of SUMOylation components during mouse brain development.
Hasegawa Y; Yoshida D; Nakamura Y; Sakakibara S
J Comp Neurol; 2014 Sep; 522(13):3020-36. PubMed ID: 24639124
[TBL] [Abstract][Full Text] [Related]
12. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
13. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
Citro S; Chiocca S
Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
[TBL] [Abstract][Full Text] [Related]
15. Gene expression and cell growth are modified by silencing SUMO2 and SUMO3 expression.
Yang W; Paschen W
Biochem Biophys Res Commun; 2009 Apr; 382(1):215-8. PubMed ID: 19275883
[TBL] [Abstract][Full Text] [Related]
16. Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.
Liu J; Sha M; Wang Q; Ma Y; Geng X; Gao Y; Feng L; Shen Y; Shen Y
BMC Cancer; 2015 Oct; 15():675. PubMed ID: 26458400
[TBL] [Abstract][Full Text] [Related]
17. Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases.
Wang W; Matunis MJ
Cells; 2023 Dec; 13(1):. PubMed ID: 38201212
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.
Higginbotham JM; O'Shea CC
J Virol; 2015 Oct; 89(20):10260-72. PubMed ID: 26223632
[TBL] [Abstract][Full Text] [Related]
19. [SUMO-2/3 can covalently bind to progesterone receptor B to regulate its transcriptional activity].
Han BY; Li FC; Cheng L; Xu XJ; Jiang K; Fu J; Han YJ; Lv ZH; Dou JT; Zhang H; Ye QN
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1493-7. PubMed ID: 21945751
[TBL] [Abstract][Full Text] [Related]
20. Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex.
Lee J; Lee Y; Lee MJ; Park E; Kang SH; Chung CH; Lee KH; Kim K
Mol Cell Biol; 2008 Oct; 28(19):6056-65. PubMed ID: 18644859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
